Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
Location status: Recruiting
Location contact
Stephanie McNew, B.S.
CONTACT
Swathi Eluri, M.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07169799
The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32224, United States
Location status: Recruiting
Stephanie McNew, B.S.
CONTACT
Swathi Eluri, M.D.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
o Medical records must show indication that each transfusion was for presumed GAVE-related bleeding.
o Either treatment-naïve or ≤ 3 prior endoscopic ablation sessions for GAVE.
Exclusion criteria
o Active peptic-ulcer disease, inflammatory bowel disease, severe portal-hypertensive gastropathy, or untreated esophageal/gastric varices.
o Known bleeding disorder or acquired coagulopathy not attributable to GAVE.
o Pregnant or breastfeeding, or planning pregnancy within 6 months of consent.
o Previous cryoballoon ablation for GAVE.
This treatment consists of performing a diagnostic EGD to identify GAVE lesions. A catheter advances through the therapeutic channel to treat target areas with cryotherapy.
Other names: Procedure: EGD and truFreeze® spray-cryotherapy
Time frame: over 6 month period
Changes in mean hemoglobin concentrations.
Total number of packed-RCB units during a 6-month period after treatment and 6-months prior to treatment (retrospective review)
Time frame: over 6 month period
Endoscopic success (as assessed by independent endoscopic image review) measured safety of the cryotherapy procedure (adverse event tracking and assessments) change in means of patient's quality of life (measured by SF-12)
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
Evaluating the Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06306963
Angiodysplasia, Cardiovascular Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT07127952
Angiodysplasia, Cardiovascular Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06772480
Angiodysplasia, Cardiovascular Diseases
New Delhi, National Capital Territory of Delhi, India
View Trial DetailsNCT04388150
Angiodysplasia, Cardiovascular Diseases
Alexandria, Egypt
View Trial Details